Efficacy and safety of acetylcysteine in "non-acetaminophen" acute liver failure: A meta-analysis of prospective clinical trials

Clinics and Research in Hepatology and Gastroenterology

Volumn 39, Issue 5, 2015, Pages 594-599

  Hu, Jinhua ^a   Zhang, Qizhi ^b   Ren, Xingye ^b   Sun, Ziqin ^a   Quan, Qizhen ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b The Fourth People's Hospital of Jinan city   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; PARACETAMOL; SCAVENGER;

ACUTE LIVER FAILURE; ALLERGIC REACTION; ARTICLE; CLINICAL TRIAL (TOPIC); COMA; CONFIDENCE INTERVAL; CONSTIPATION; CORRELATION ANALYSIS; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; EMBASE; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER TOXICITY; LIVER TRANSPLANTATION; MEDLINE; META ANALYSIS; NAUSEA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RASH; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VOMITING; INTRAVENOUS DRUG ADMINISTRATION; LIVER FAILURE, ACUTE; MORTALITY; ORAL DRUG ADMINISTRATION;

ACETAMINOPHEN; ACETYLCYSTEINE; ADMINISTRATION, ORAL; CLINICAL TRIALS AS TOPIC; FREE RADICAL SCAVENGERS; HUMANS; INFUSIONS, INTRAVENOUS; LIVER FAILURE, ACUTE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84942988285     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2015.01.003     Document Type: Article

References (10)

1. Ostapowicz G., Fontana R.J., Schiødt F.V., Larson A., Davern T.J., Han S.H., et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002, 137(12):947-954.
2. Lee W.M., Hynan L.S., Rossaro L., Fontana R.J., Stravitz R.T., Larson A.M., et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009, 137(3):856-864.
3. Mumtaz K., Azam Z., Hamid S., Abid S., Memon S., Ali Shah H., et al. Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation. Hepatol Int 2009, 3(4):563-570.
4. Singh S., Hynan L.S., Lee W.M. Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure. Dig Dis Sci 2013, 58(5):1397-1402.
5. Kortsalioudaki C., Taylor R.M., Cheeseman P., Bansal S., Mieli-Vergani G., Dhawan A. Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure. Liver Transpl 2008, 14(1):25-30.
6. Bémeur C., Vaquero J., Desjardins P., Butterworth R.F. N-acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms. Metab Brain Dis 2010, 25(2):241-249.
7. Harrison P.M., Wendon J.A., Gimson A.E., Alexander G.J., Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991, 324(26):1852-1857.
8. Harrison P., Wendon J., Williams R. Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure. Hepatology 1996, 23:1067-1072.
9. Stravitz R.T., Sanyal A.J., Reisch J., Bajaj J.S., Mirshahi F., Cheng J., et al. Acute effects of N-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival. Liver Int 2013, 33(9):1324-1331.
10. Squires R.H., Dhawan A., Alonso E., Narkewicz M.R., Shneider B.L., Rodriguez-Baez N., et al. Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology 2013, 57(4):1542-1549.